Inovio Pharmaceuticals Inc. closed 88.27% short of its 52-week high of $14.75, which the company reached on April 1st.

Shares of Inovio Pharmaceuticals Inc. INO slid 3.72% to $1.81 Tuesday, on what proved to be an all-around positive trading ...

Inovio Pharmaceuticals (NASDAQ:INO – Free Report) had its target price lowered by Royal Bank of Canada from $6.00 to $5.00 in a research report sent to investors on Wednesday,Benzinga reports. The ...

After hours: March 24 at 7:58:25 PM EDT Vertex Baseline Delta ...

Regeneron is to collaborate with Inovio to investigate a three-way immunotherapy combination against glioblastoma multiforme (GBM), an aggressive and hard-to-treat brain tumour. Regeneron’s drug ...

WASHINGTON, March 24 (Reuters) - U.S. President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals. Speaking to reporters at ...

A vial of Botox, sold by AbbVie, is seen next to its packaging in a photo illustration in Manhattan, New York, U.S., December 8, 2021. REUTERS/Andrew Kelly/File Photo Some drugmakers are taking ...

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

It later moved into medicines, commercialising aspirin around the turn of the 20th century, one of the most successful pharmaceuticals ever at that point. The unregulated nature of the trade in ...